Paroxysmal Nocturnal Hemoglobinuria (PNH)
What is Paroxysmal nocturnal hemoglobinuria (PNH)?
Paroxysmal nocturnal hemoglobinuria, or PNH, is a rare acquired blood disorder. Your body mistakenly destroys its own red blood cells. This happens when your immune system attacks healthy blood cells through a process called complement-mediated hemolysis.
PNH develops when a genetic mutation occurs in your bone marrow stem cells. The mutation prevents cells from making proteins that normally protect them from immune attack. Red blood cells without this protection get destroyed in your bloodstream. This destruction can lead to anemia, blood clots, and organ damage over time.
The condition is called paroxysmal because symptoms can come and go suddenly. It is called nocturnal because early observations suggested symptoms worsened at night. However, hemolysis can happen at any time of day. PNH is progressive and requires ongoing monitoring to prevent serious complications.
Symptoms
Common symptoms of PNH include:
- Dark or tea-colored urine, especially in the morning
- Extreme fatigue and weakness from anemia
- Shortness of breath during physical activity
- Rapid or irregular heartbeat
- Difficulty swallowing or chest pain
- Abdominal pain and cramping
- Headaches and confusion
- Erectile dysfunction in men
- Pale skin and yellowing of the eyes
- Frequent infections
Some people with PNH experience mild symptoms for years before diagnosis. Others develop severe complications like blood clots quickly. Symptom severity often relates to how many red blood cells are being destroyed.
Concerned about Paroxysmal nocturnal hemoglobinuria (PNH)? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
PNH is caused by a random mutation in the PIGA gene within bone marrow stem cells. This mutation is acquired during your lifetime, not inherited from parents. The mutated stem cells produce blood cells missing key protective proteins. Your immune system's complement pathway then destroys these unprotected red blood cells.
Researchers do not fully understand what triggers the initial mutation. PNH often develops in people with bone marrow failure disorders like aplastic anemia. About 30 percent of people with PNH have a history of aplastic anemia. Other risk factors include myelodysplastic syndrome and prior bone marrow stress. The condition affects men and women equally and typically appears between ages 30 and 40.
How it's diagnosed
Doctors diagnose PNH using specialized blood tests that detect abnormal blood cells. Flow cytometry is the gold standard test that identifies cells missing protective proteins. Regular monitoring of red blood cell count helps assess how much hemolysis is occurring. A low RBC count indicates your body is destroying red blood cells faster than it can replace them.
Rite Aid offers blood testing that includes red blood cell count monitoring. This helps track anemia severity and guide treatment decisions. Your doctor may order additional specialized tests like lactate dehydrogenase to measure cell destruction. Reticulocyte count shows how well your bone marrow is responding. Early and regular testing is essential for managing PNH and preventing life-threatening complications.
Treatment options
Treatment for PNH focuses on reducing hemolysis and managing complications:
- Complement inhibitor medications like eculizumab or ravulizumab to prevent cell destruction
- Blood transfusions to treat severe anemia and maintain healthy RBC levels
- Folic acid and iron supplements to support red blood cell production
- Anticoagulant medications to prevent dangerous blood clots
- Bone marrow transplant in severe cases, the only potential cure
- Vaccinations to prevent infections, especially meningococcal disease
- Regular blood monitoring to track disease progression
- Avoiding triggers like infection and physical stress when possible
Work closely with a hematologist experienced in treating rare blood disorders. Treatment plans are highly individualized based on symptom severity and complications. Many people with PNH require lifelong therapy and monitoring.
Concerned about Paroxysmal nocturnal hemoglobinuria (PNH)? Get tested at Rite Aid.
- Simple blood draw at your nearest lab
- Results in days, not weeks
- Share results with your doctor
Frequently asked questions
PNH is unique because your immune system actively destroys red blood cells in your bloodstream. This is called intravascular hemolysis. Unlike nutritional anemias, PNH results from a genetic mutation in bone marrow stem cells. The destruction happens continuously and can cause serious complications like blood clots that other anemias typically do not cause.
Dark urine occurs when destroyed red blood cells release hemoglobin into your bloodstream. Your kidneys filter this hemoglobin and excrete it in urine. The color is often darkest in morning urine because hemolysis accumulates overnight. This is one of the hallmark signs of PNH and indicates active red blood cell destruction.
Testing frequency depends on your disease severity and treatment plan. Most people need blood work every few weeks to months to monitor red blood cell counts. Regular testing helps your doctor assess if treatment is working. More frequent testing may be needed during flares or when adjusting medications.
PNH rarely goes away spontaneously, though mild cases can remain stable for years. Without treatment, the condition typically progresses and causes serious complications. Blood clots are the leading cause of death in untreated PNH. Modern complement inhibitor medications have dramatically improved outcomes and quality of life for most patients.
About 30 percent of people with PNH have a history of aplastic anemia, a bone marrow failure disorder. Both conditions involve problems with bone marrow stem cells. Some patients develop PNH after recovering from aplastic anemia. Others have both conditions simultaneously, which requires careful management of both disorders.
Yes, blood clots are a major complication of PNH and occur in about 40 percent of patients. Clots can form in unusual places like abdominal veins or brain vessels. Destroyed red blood cells release substances that promote clotting. This makes anticoagulation therapy important for many people with PNH, especially those with high hemolysis rates.
Many people with PNH require blood transfusions to manage severe anemia. Transfusions provide healthy red blood cells when your body cannot produce enough. The need for transfusions depends on your hemolysis rate and symptoms. Complement inhibitor medications have reduced transfusion needs for many patients.
While lifestyle changes cannot cure PNH, they can help you manage symptoms better. Getting adequate rest helps combat fatigue. Staying hydrated may reduce hemolysis episodes. Avoiding infections through good hygiene and vaccinations is critical because illness can trigger flares.
PNH is not inherited and you cannot pass it to your children. The genetic mutation occurs randomly in your bone marrow cells during your lifetime. It affects only blood cells, not reproductive cells. Your children have the same risk of developing PNH as the general population, which is very low.
Complement inhibitors are medications that block your immune system's complement pathway. This pathway normally destroys bacteria but mistakenly attacks red blood cells in PNH. Medications like eculizumab and ravulizumab prevent this attack. These drugs have transformed PNH from a life-threatening condition to a manageable chronic disease for most patients.